These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1998640)

  • 1. Quantification of fibrin deposition in flowing blood with peroxidase-labeled fibrinogen. High shear rates induce decreased fibrin deposition and appearance of fibrin monomers.
    Tijburg PN; Ijsseldijk MJ; Sixma JJ; de Groot PG
    Arterioscler Thromb; 1991; 11(2):211-20. PubMed ID: 1998640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of endothelial cells induces platelet thrombus formation on their matrix. Studies of new in vitro thrombosis model with low molecular weight heparin as anticoagulant.
    Zwaginga JJ; Sixma JJ; de Groot PG
    Arteriosclerosis; 1990; 10(1):49-61. PubMed ID: 2297347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of procoagulant activity of extracellular endothelial matrix by anti-tissue factor antibody and the synthetic peptide Arg-Gly-Asp-Val. Experiments with flowing non-anticoagulated human blood.
    Salatti JA; Anton P; Nemerson Y; Sakariassen KS
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):881-90. PubMed ID: 8148480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombogenicity of vascular cells. Comparison between endothelial cells isolated from different sources and smooth muscle cells and fibroblasts.
    Zwaginga JJ; de Boer HC; IJsseldijk MJ; Kerkhof A; Muller-Berghaus G; Gruhlichhenn J; Sixma JJ; de Groot PG
    Arteriosclerosis; 1990; 10(3):437-48. PubMed ID: 2344300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets.
    Mailhac A; Badimon JJ; Fallon JT; Fernández-Ortiz A; Meyer B; Chesebro JH; Fuster V; Badimon L
    Circulation; 1994 Aug; 90(2):988-96. PubMed ID: 8044972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procoagulant activity of endotoxin-treated human endothelial cells exposed to native human flowing blood.
    Clozel M; Kuhn H; Baumgartner HR
    Blood; 1989 Feb; 73(3):729-33. PubMed ID: 2917195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new method for quantifying platelet deposition in flowing native blood in an ex vivo model of human thrombogenesis.
    Bossavy JP; Sakariassen KS; Barret A; Boneu B; Cadroy Y
    Thromb Haemost; 1998 Jan; 79(1):162-8. PubMed ID: 9459343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab.
    Dangas G; Badimon JJ; Coller BS; Fallon JT; Sharma SK; Hayes RM; Meraj P; Ambrose JA; Marmur JD
    Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1342-9. PubMed ID: 9714143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute thrombogenicity of intact and injured natural blood conduits versus synthetic conduits: neutrophil, platelet, and fibrin(ogen) adsorption under various shear-rate conditions.
    Merhi Y; King M; Guidoin R
    J Biomed Mater Res; 1997 Mar; 34(4):477-85. PubMed ID: 9054531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombogenesis of different cell types seeded on vascular grafts and studied under blood-flow conditions.
    Hedeman Joosten PP; Verhagen HJ; Heijnen-Snyder GJ; van Vroonhoven TJ; Sixma JJ; de Groot PG; Eikelboom BC
    J Vasc Surg; 1998 Dec; 28(6):1094-103. PubMed ID: 9845661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin glue containing fibroblast growth factor type 1 and heparin decreases platelet deposition.
    Zarge JI; Husak V; Huang P; Greisler HP
    Am J Surg; 1997 Aug; 174(2):188-92. PubMed ID: 9293842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the oral anticoagulant phenprocoumon on blood coagulation and thrombogenesis induced by rabbit aorta subendothelium exposed to flowing human blood: role of dose and shear rate.
    Inauen W; Bombeli T; Baumgartner HR; Haeberli A; Straub PW
    J Lab Clin Med; 1991 Sep; 118(3):280-8. PubMed ID: 1919300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active site-blocked factors VIIa and IXa differentially inhibit fibrin formation in a human ex vivo thrombosis model.
    Kirchhofer D; Tschopp TB; Baumgartner HR
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1098-106. PubMed ID: 7627702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of fibulin-1 with fibrinogen. A potential role in hemostasis and thrombosis.
    Tran H; Tanaka A; Litvinovich SV; Medved LV; Haudenschild CC; Argraves WS
    J Biol Chem; 1995 Aug; 270(33):19458-64. PubMed ID: 7642629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet deposition on ePTFE grafts coated with fibrin glue with or without FGF-1 and heparin.
    Zarge JI; Gosselin C; Huang P; Vorp DA; Severyn DA; Greisler HP
    J Surg Res; 1997 Jan; 67(1):4-8. PubMed ID: 9070173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibers Generated by Plasma Des-AA Fibrin Monomers and Protofibril/Fibrinogen Clusters Bind Platelets: Clinical and Nonclinical Implications.
    Galanakis DK; Protopopova A; Zhang L; Li K; Marmorat C; Scheiner T; Koo J; Savitt AG; Rafailovich M; Weisel J
    TH Open; 2021 Jul; 5(3):e273-e285. PubMed ID: 34240000
    [No Abstract]   [Full Text] [Related]  

  • 18. The hemodynamics of thrombus formation in arteries.
    Ouriel K; Donayre C; Shortell CK; Cimino C; Donnelly J; Oxley D; Green RM
    J Vasc Surg; 1991 Dec; 14(6):757-62; discussion 762-3. PubMed ID: 1960805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between endothelial tissue factor and thrombogenesis under blood flow conditions.
    Diquélou A; Dupouy D; Gaspin D; Constans J; Sié P; Boneu B; Sakariassen KS; Cadroy Y
    Thromb Haemost; 1995 Aug; 74(2):778-83. PubMed ID: 8585021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombus formation on polytetrafluoroethylene surfaces: the importance of von Willebrand factor.
    Cho JS; Ouriel K; DeWeese JA; Green RM; Chen GY; Stoughton J
    Cardiovasc Surg; 1995 Dec; 3(6):645-51. PubMed ID: 8745188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.